Redox-Active Cerium Oxide Nanoparticles Protect Against Acetaminophen-Induced Acute Liver Injury by Modulating...

Area of Science:

• Nanomedicine
• Materials Science
• Toxicology

Background:

• Acute liver injury (ALI), often from acetaminophen (APAP) overdose, involves oxidative stress, inflammation, and cell death.
• Existing treatments like N-acetylcysteine (NAC) have limitations, necessitating advanced antioxidant strategies.
• Cerium oxide nanoparticles (nanoceria) possess unique redox properties with potential therapeutic applications.

Purpose of the Study:

• To synthesize and characterize nanoceria for their antioxidant and anti-inflammatory properties.
• To evaluate the efficacy of nanoceria in mitigating APAP-induced ALI in a mouse model.
• To elucidate the underlying mechanisms of nanoceria's hepatoprotective effects.

Main Methods:

• Nanoceria synthesis and characterization (TEM, DLS, XRD, XPS).
• In vitro assays for antioxidant activity (ROS scavenging) and cytocompatibility.
• In vivo studies using an APAP-induced ALI mouse model to assess liver injury markers and inflammatory responses.

Main Results:

• Nanoceria demonstrated excellent cytocompatibility and potent scavenging of reactive oxygen species (ROS).
• In macrophages, nanoceria suppressed LPS-induced inflammation and apoptosis.
• In APAP-induced ALI mice, nanoceria reduced liver damage, oxidative stress, and inflammation, showing efficacy comparable to NAC.

Conclusions:

• Nanoceria exhibit significant hepatoprotective effects against APAP-induced ALI through combined antioxidant and anti-inflammatory actions.
• The therapeutic mechanism involves synergistic effects driven by the Ce3+/Ce4+ redox cycling of nanoceria.
• Nanoceria represent a promising next-generation nanotherapeutic for treating oxidative stress-related liver diseases.